We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the various public portfolio startups of the fund, we may underline Nohla Therapeutics Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the AML Biotech Partners, startups are often financed by ARCH Venture Partners, 5AM Ventures, The Jagen Group. The meaningful sponsors for the fund in investment in the same round are Fidelity Management and Research Company, Celgene, ARCH Venture Partners. In the next rounds fund is usually obtained by UTEC- University of Tokyo Edge Capital, Schroder Adveq, Premier Partners.
The important activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
Fund Name | Location |
Bitcoin Investment Trust | New York, New York, United States |
Bru Venture Capital | Gullbringusysla, Iceland, Reykjavík |
D2M | California, Sunnyvale, United States |
Doorway Capital | England, London, United Kingdom |
DW Fund | China, Shanghai, Xuhui |
Globant | Chicago, Illinois, United States |
InMobi | Bangalore, India, Karnataka |
Meadow Lane Investments | Ohio, Reynoldsburg, United States |
New World TMT Ltd | China, Hong Kong, Hong Kong Island |
Ocean Azul Partners | Florida, Miami, United States |
PineCypress Fund | Beijing, Beijing, China |
Qianshi Investment | China, Shanghai |
Riekeles Finans | Norway, Oslo |
Russia-Japan Investment Fund | - |
Startupbootcamp InsurTech London | England, London, United Kingdom |
SV Links | California, Menlo Park, United States |
Trade Me | New Zealand, Wellington, Wellington |
Tumml | California, San Francisco, United States |
Velocity Technology Partners | Athens, Georgia, United States |
Yellow Ventures | Brazil, São Paulo, Sao Paulo |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Nohla Therapeutics | $11M | 12 Jul 2018 | Seattle, Washington, United States | ||
Nohla Therapeutics | $45M | 15 May 2018 | Seattle, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Nohla Therapeutics | $11M | 12 Jul 2018 | Seattle, Washington, United States | ||
Nohla Therapeutics | $45M | 15 May 2018 | Seattle, Washington, United States |